Background
A global healthcare company headquartered in Europe used best-in-class approaches to launch a rare disease drug in the US. After a year on the market, the leadership team recognized the need for innovative solutions that could help grow business further. We were approached to solve one key question: “How to active more patients for Product X in a way that creates value for patients, providers, and the company?”